Track Rain Therapeutics Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Rain Therapeutics Inc. RAIN · Stock Open Rain Therapeutics Inc. in new tab

0.8689 USD
EPS
-1.51
P/B
-0.46
Beta
-0.22
Loading chart...
Key Metrics
Earnings dateNov. 12, 2026
EPS-1.51
Book Value-1.18
Price to Book-0.46
% Insiders61.489%

DCF valuation

Model fair value for Rain Therapeutics Inc. (RAIN)
Result
Sign in to run the valuation for RAIN.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Rain Therapeutics Inc. Analysis (RAIN)

United States Health Care Stock

Is Rain Therapeutics Inc. a good investment? Rain Therapeutics Inc. (RAIN) is currently trading at 0.8689 USD.

Earnings Schedule: Rain Therapeutics Inc. is expected to release its next earnings report on Nov. 12, 2026.

Investor FAQ

Does Rain Therapeutics Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Rain Therapeutics Inc.?

Rain Therapeutics Inc. is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Nov. 12, 2026. The company currently has a trailing EPS of -1.51.

Company Profile

Rain Enhancement Technologies Holdco, Inc. develops, improves, and commercializes atmospheric enhancement by ionization (AEI) technology. It plans to develop improvements on existing rainfall generation technologies by introducing robust measurement tools, including software monitoring technology, machine learning, rain gauges, and weather stations. The company was founded in 2022 and is headquartered in Naples, Florida.

Trades
No dividend information available for this instrument.

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion